Skip to main content
Smart Investors Daily
NV

NYSE · NVST

Envista Holdings Corp

Healthcare · Medical - Equipment & Services

$28.07

Down-$0.01 (-0.04%)

Updated Aug 15, 2026, 2:08 PM

SID Score

5.2/10

Composite research score

Smart Money

58/100

Neutral

Market cap
3.64B
P/E ratio
244.84
Dividend yield
0.00%
52-week range
$22.36 – $29.53
Volume
2.53M
Avg. volume
2.08M

Price performance

NVST price history

1M range · 21 trading sessions · Daily adjusted prices

NVST closed at $28.07 after 21 trading sessions, up 4.97% for the selected period.

Last close
$28.07
Period change
+4.97%
Period low
$26.17
Period high
$28.71
Daily close
View OHLC price history
NVST OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 14, 2026$28.00$28.42$27.925$28.072.53M
Aug 13, 2026$28.90$29.00$27.87$28.082.65M
Aug 12, 2026$28.26$28.90$28.01$28.712.53M
Aug 11, 2026$28.12$28.99$27.914$28.522.64M
Aug 10, 2026$27.76$28.36$27.60$28.193.07M
Aug 7, 2026$27.60$28.53$27.395$28.154.07M
Aug 6, 2026$28.70$28.70$27.12$27.386.02M
Aug 5, 2026$27.97$28.68$27.6613$28.637M
Aug 4, 2026$27.44$28.00$27.32$27.963.18M
Aug 3, 2026$27.57$27.97$27.095$27.373.02M
Jul 31, 2026$27.68$27.68$26.85$27.313.16M
Jul 30, 2026$28.00$28.74$27.6651$27.782.57M
Jul 29, 2026$27.99$28.845$27.66$28.376.05M
Jul 28, 2026$26.81$27.41$26.74$26.962.39M
Jul 27, 2026$26.57$26.80$26.35$26.642.04M
Jul 24, 2026$26.23$26.765$26.15$26.331.86M
Jul 23, 2026$26.24$26.55$25.76$26.172.74M
Jul 22, 2026$26.92$27.09$26.335$26.431.93M
Jul 21, 2026$26.50$27.025$26.46$26.931.72M
Jul 20, 2026$26.78$27.00$26.505$26.581.72M
Jul 17, 2026$26.71$27.31$26.61$26.741.79M

Latest NVST news

The latest Smart Investors Daily articles mentioning NVST.

NVST research

Overview

Company profile and research snapshot.

Company profile

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$24.00
Implied upside
Analysts
NVST recent ratings
DateFirmRatingTarget
Aug 6, 2026Piper SandlerNeutral
Jul 29, 2026Piper SandlerNeutral
Jul 9, 2026BMO CapitalMarket Perform
Jun 11, 2026BarclaysOverweight
May 7, 2026Evercore ISI GroupOutperform
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Aug 9, 2026

Will Envista’s Strong Q2 and Raised 2026 Guidance Change Envista Holdings' (NVST) Narrative

Envista Holdings Corporation recently reported Q2 2026 results showing higher sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33. Alongside these results, Envista completed share repurchases totaling 12,458,894 shares for US$250 million, while also raising its full-year 2026 guidance despite expected pricing pressure in China. Now we will examine how Envista’s raised full-year guidance and earnings momentum...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.